Adma Biologics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Adma Biologics
Tip: Access up to 7 years of quarterly data
All positions including Adma Biologics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Adma Biologics by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $2.6M | 130k | 19.99 |
2024-06-30 | $1.5M | 130k | 11.18 |
2023-12-31 | $499k | 111k | 4.52 |
2023-09-30 | $396k | 111k | 3.58 |
2023-06-30 | $408k | 111k | 3.69 |
2023-03-31 | $366k | 111k | 3.31 |
2022-12-31 | $339k | 87k | 3.88 |
2022-09-30 | $239k | 98k | 2.43 |
2022-06-30 | $195k | 98k | 1.98 |
2020-03-31 | $106k | 37k | 2.88 |
2019-09-30 | $117k | 26k | 4.44 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors